Literature DB >> 1893615

A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE).

A Khalili1, R C Cooper.   

Abstract

Sera from 39 patients with SLE, 20 patients with cerebrovascular disease with no evidence of SLE, and 20 normal controls were tested for antibodies to cardiolipin (CL), brain total upper (UPG) and lower phase (LPG) glycolipids, myelin basic protein (MBP), myelin, and single strand DNA (ssDNA) by ELISA. Binding to the glycolipids and MBP was negative or negligible in all the groups, but significant binding was observed against CL, myelin and ssDNA in some of the SLE patients. Many sera from SLE patients with cerebral disorders and high CL binding also demonstrated high binding to myelin. These sera also labelled cell surface antigens on neonatal mouse neurons and astrocytes by immunofluorescence in tissue culture. A correlation was found to exist between anti-CL and antimyelin antibodies in SLE patients with cerebral lesions, but not between anti-ssDNA and anti-CL antibodies. As much as 80-90% of the specific activity of these antibodies could be absorbed out by the relevant antigens but only partially by the other antigens. In the control groups binding was low and no specific absorption could be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893615      PMCID: PMC1535606          DOI: 10.1111/j.1365-2249.1991.tb05733.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity.

Authors:  C B Colaço; D K Male
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

2.  Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder.

Authors:  C G Mackworth-Young; S Loizou; M J Walport
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

3.  Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus.

Authors:  C E Weidmann; D J Wallace; J B Peter; P J Knight; M B Bear; J R Klinenberg
Journal:  J Rheumatol       Date:  1988-01       Impact factor: 4.666

4.  Analysis of autoantibody specificities in selected systemic lupus erythematosus (SLE) sera.

Authors:  A M Francoeur
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

5.  Affinity purified anti-cardiolipin and anti-DNA antibodies.

Authors:  E N Harris; A E Gharavi; A Tincani; J K Chan; H Englert; P Mantelli; F Allegro; G Ballestrieri; G R Hughes
Journal:  J Clin Lab Immunol       Date:  1985-08

6.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

Authors:  A E Gharavi; E N Harris; R A Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

Review 7.  Antiphospholipid antibodies--autoantibodies with a difference.

Authors:  E N Harris; R A Asherson; G R Hughes
Journal:  Annu Rev Med       Date:  1988       Impact factor: 13.739

8.  Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.

Authors:  M D Lockshin; M L Druzin; S Goei; T Qamar; M S Magid; L Jovanovic; M Ferenc
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

9.  Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice.

Authors:  K B Elkon; E Bonfa; R Llovet; R A Eisenberg
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

10.  Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein; G W Williams; A D Steinberg
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

View more
  5 in total

1.  Diffusion tensor imaging in patients with obstetric antiphospholipid syndrome without neuropsychiatric symptoms.

Authors:  Fabricio R Pereira; Francesco Macri; Marcel P Jackowski; William J Kostis; Jean-Christophe Gris; Jean-Paul Beregi; Choukri Mekkaoui
Journal:  Eur Radiol       Date:  2015-07-23       Impact factor: 5.315

Review 2.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

3.  Increased anti-phospholipid antibodies in autism spectrum disorders.

Authors:  Milo Careaga; Robin L Hansen; Irva Hertz-Piccotto; Judy Van de Water; Paul Ashwood
Journal:  Mediators Inflamm       Date:  2013-09-23       Impact factor: 4.711

4.  Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.

Authors:  J Terryberry; M Sutjita; Y Shoenfeld; B Gilburd; D Tanne; M Lorber; I Alosachie; N Barka; H C Lin; P Youinou
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

Review 5.  Neuropsychiatric Manifestations of Antiphospholipid Syndrome-A Narrative Review.

Authors:  Yik Long Man; Giovanni Sanna
Journal:  Brain Sci       Date:  2022-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.